Cognitive disorders in people living with HIV

A Winston, S Spudich - The Lancet HIV, 2020 - thelancet.com
High rates of cognitive disorders in antiretroviral-treated people living with HIV have been
described worldwide. The exact prevalence of such cognitive disorders is determined by the …

Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America

MA Thompson, MA Horberg, AL Agwu… - Clinical infectious …, 2021 - academic.oup.com
Advances in antiretroviral therapy (ART) have made it possible for persons with human
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel

MS Saag, RT Gandhi, JF Hoy, RJ Landovitz… - Jama, 2020 - jamanetwork.com
Importance Data on the use of antiretroviral drugs, including new drugs and formulations, for
the treatment and prevention of HIV infection continue to guide optimal practices. Objective …

[HTML][HTML] Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis — United States, 2013–2018

NS Harris - MMWR. Morbidity and mortality weekly report, 2019 - cdc.gov
Background: Approximately 38,000 new human immunodeficiency virus (HIV) infections
occur in the United States each year; these infections can be prevented. A proposed …

Redefining therapeutic success in HIV patients: an expert view

A Antela, A Rivero, JM Llibre… - Journal of Antimicrobial …, 2021 - academic.oup.com
Thanks to advances in the field over the years, HIV/AIDS has now become a manageable
chronic condition. Nevertheless, a new set of HIV-associated complications has emerged …

Evaluation of a novel community-based COVID-19 'Test-to-Care'model for low-income populations

AD Kerkhoff, D Sachdev, S Mizany, S Rojas, M Gandhi… - PloS one, 2020 - journals.plos.org
Background After a COVID-19 diagnosis, vulnerable populations face considerable
logistical and financial challenges to isolate and quarantine. We developed and evaluated a …

Getting to zero San Francisco: a collective impact approach

SP Buchbinder, DV Havlir - JAIDS Journal of Acquired Immune …, 2019 - journals.lww.com
Background: Building on several decades of innovative HIV prevention and treatment
programming in San Francisco, in 2014, a small group of academic, civic, and community …

Evidence regarding rapid initiation of antiretroviral therapy in patients living with HIV

SM Michienzi, M Barrios, ME Badowski - Current Infectious Disease …, 2021 - Springer
Abstract Purpose of Review Rapid initiation of antiretroviral therapy (ART) is increasingly
more common among clinics serving people living with human immunodeficiency virus …

Stopping, starting, and sustaining HIV antiretroviral therapy: a mixed-methods exploration among African American/Black and Latino long-term survivors of HIV in an …

M Gwadz, CM Cleland, R Freeman, L Wilton… - BMC Public Health, 2021 - Springer
Background Although periods of HIV antiretroviral therapy (ART) discontinuation have
deleterious health effects, ART is not always sustained. Yet, little is known about factors that …

DOLAVI real-life study of dolutegravir plus lamivudine in naive HIV-1 patients (48 weeks)

C Hidalgo-Tenorio, J Pasquau, D Vinuesa, S Ferra… - Viruses, 2022 - mdpi.com
Brief: Real-world data in naïve HIV-1 patients demonstrate that dolutegravir plus lamivudine
in a multiple tablet regimen is effective, safe, and satisfactory; it causes moderately …